Beta Drugs (India) Price on December 5, 2024
| BETA Stock | 2,127 2.50 0.12% |
Below is the normalized historical share price chart for Beta Drugs extending back to October 12, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Beta Drugs stands at 2,127, as last reported on the 19th of December, with the highest price reaching 2,153 and the lowest price hitting 2,095 during the day.
If you're considering investing in Beta Stock, it is important to understand the factors that can impact its price. Beta Drugs appears to be very steady, given 3 months investment horizon. Beta Drugs secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Beta Drugs, which you can use to evaluate the volatility of the firm. Please makes use of Beta Drugs' Risk Adjusted Performance of 0.0789, mean deviation of 2.3, and Downside Deviation of 2.66 to double-check if our risk estimates are consistent with your expectations.
Beta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Beta |
Sharpe Ratio = 0.1305
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BETA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.15 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Beta Drugs is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beta Drugs by adding it to a well-diversified portfolio.
Beta Drugs Main Headline on 5th of December 2024
Oncology-focused Beta Drugs raises Rs 117 crore from Healthq... by news.google.com
Oncology-focused Beta Drugs raises Rs 117 crore from Healthquad, others MSN
Beta Drugs Valuation on December 5, 2024
It is possible to determine the worth of Beta Drugs on a given historical date. On December 5, 2024 Beta was worth 2215.0 at the beginning of the trading date compared to the closed value of 2242.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Beta Drugs stock. Still, in general, we apply an absolute valuation method to find Beta Drugs' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Beta Drugs where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Beta Drugs' related companies.
| Open | High | Low | Close | Volume | |
| 2,258 | 2,258 | 2,216 | 2,241 | 1,900 | |
12/05/2024 | 2,215 | 2,266 | 2,215 | 2,243 | 5,900 |
| 2,240 | 2,273 | 2,196 | 2,198 | 6,400 |
| Backtest Beta Drugs | | | Beta Drugs History | Previous | Next |
Beta Drugs Trading Date Momentum on December 5, 2024
| On December 06 2024 Beta Drugs was traded for 2,198 at the closing time. The highest price during the trading period was 2,273 and the lowest recorded bid was listed for 2,196 . The volume for the day was 6.4 K. This history from December 6, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 1.99% . The overall trading delta to the current price is 3.19% . |
About Beta Drugs Stock history
Beta Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Beta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Beta Drugs will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Beta Drugs stock prices may prove useful in developing a viable investing in Beta Drugs
Beta Drugs Stock Technical Analysis
Beta Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Beta Drugs Period Price Range
Low | December 19, 2024
| High |
0.00 | 0.00 |
Beta Drugs cannot be verified against its exchange. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Beta Drugs December 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Beta Drugs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Beta Drugs shares will generate the highest return on investment. By undertsting and applying Beta Drugs stock market strength indicators, traders can identify Beta Drugs entry and exit signals to maximize returns
Beta Drugs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Beta Drugs' price direction in advance. Along with the technical and fundamental analysis of Beta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Beta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0789 | |||
| Jensen Alpha | 0.261 | |||
| Total Risk Alpha | 0.1947 | |||
| Sortino Ratio | 0.094 | |||
| Treynor Ratio | 0.6175 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.